tm
Seeing Is Believing
tm
Seeing Is Believing
Inhibikase Therapeutics 's activity chart (see below) currently has 30 price targets and 26 ratings on display.
Analysts average stock forecasts to be materialized ratio is 14.58% with an average time for these price targets to be met of 99.38 days.
Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 28-Mar-2025. First documented stock forecast 13-Jan-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Feb-2025
1 years 5 months 17 days ago
(28-Mar-2025)
0/2 (0%)
$3.41 (214.47%)
Hold Since 16-Nov-2022
$72
3 years 9 months 29 days ago
(16-Nov-2022)
0/1 (0%)
$56.82 (374.31%)
Sell Since 07-Mar-2021
4 years 1 months 13 days ago
(01-Aug-2022)
0/2 (0%)
$46.55 (145.02%)
Buy Since 02-Mar-2021
$90.25
4 years 3 months 18 days ago
(27-May-2022)
2/6 (33.33%)
$51.91 (135.39%)
256
Buy Since 03-Jun-2021
$88.33
5 years 3 months 11 days ago
(03-Jun-2021)
1/3 (33.33%)
$49.81 (129.31%)
268
What is IKT (Inhibikase Therapeutics ) average time for price targets to be met?
Which analyst most recently updated their price target on IKT (Inhibikase Therapeutics )?
Which analyst has the current lower performing score on IKT (Inhibikase Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on IKT (Inhibikase Therapeutics )?
Which analyst is the currently most bullish on IKT (Inhibikase Therapeutics )?
Which analyst is the currently most reserved on IKT (Inhibikase Therapeutics )?
